FXEMPIRE
All
Ad
Corona Virus
Stay Safe, FollowGuidance
World
98,398,725Confirmed
2,107,324Deaths
70,685,355Recovered
Fetching Location Data…
Advertisement
Advertisement
James Hyerczyk
Asia Pacific Stock Indexes

The major Asia-Pacific stock indexes finished mixed, but mostly lower on Thursday with South Korea coming out the lone winner for the session. The trade was a little tentative as investors continued to digest the data from the reopening of global economies amid the coronavirus pandemic.

The World Health Organization said the number of newly reported cases globally hit a daily record this week, amid authorities around the world attempting to ease lockdown measures put in place to curb the virus’ spread.

On Thursday, Japan’s Nikkei 225 Index settled at 20552.31, down 42.84 or -0.21. Hong Kong’s Hang Seng Index finished at 24280.03, down 119.92 or -0.49% and South Korea’s KOSPI Index closed at 1998.31, up 8.67 or +0.44%.

China’s Shanghai Index settled at 2867.92, down 15.81 or -0.55% and Australia’s S&P/ASX 200 Index closed at 5550.40, down 22.60 or -0.41%.

Absent from the trade on Thursday was the euphoria fueled on Monday after Moderna announced a positive development for a potential coronavirus vaccine. This is because on Wednesday, a STAT News report said vaccine experts were skeptical of Moderna’s new vaccine data. In response to the report, Moderna’s CEO said the company would never put out data that was different from “reality.”

Australian Stock Market

Australia made the deepest dividend cuts globally this year, with more than $6 billion deferred or cancelled as companies conserve cash to ride out the coronavirus, turning foreign investors wary of the country’s normally high-yielding firms, according to Reuters.

Payout changes have been announced over the past two months and strategists believe more are coming as companies sign off annual accounts on June 30.

Financials comprise more than a quarter of the benchmark stock price index and, under pressure to demonstrate stability to regulators, account for the steepest cuts.

Advertisement

Hong Kong Stock Market

Hong Kong stocks slipped on Thursday, dragged down by technology shares, after U.S. officials said regulators were open to making changes to close a possible loophole in a new rule aimed at curbing global chip sales to Chinese firm Huawei Technologies.

A U.S. State Department official said the rule, which currently includes chips designed by Huawei and doesn’t cover shipments if they are sent directly to the company’s customers – will be watched by regulators and “certainly make any changes that we think are necessary.”

Investors also awaited China’s parliamentary meeting, where Premier Li Keqiang is expected to make a state-of-the-nation style address and reiterate Beijing’s long-standing vow to keep the Yuan stable.

Japan Stock Market

Japan’s Nikkei share average snapped a four-day winning streak on Thursday, as investors were reluctant to chase markets after the benchmark hit a 2-1/2-month high, raising concerns that stocks were potentially overvalued.

Although the market has rallied on hopes of a quick economic recovery following countries’ move to ease coronavirus restrictions, investors have noted the market’s valuations are getting stretched, according to Reuters.

The Japanese government is expected to lift its state of emergency later in the day in three prefectures around Osaka, the country’s second-biggest urban area after Tokyo, and might take similar steps for Tokyo by the end of the month.

Don't miss a thing!
Discover what's moving the markets. Sign up for a daily update delivered to your inbox

Trade With A Regulated Broker

  • Your capital is at risk
IMPORTANT DISCLAIMERS
The content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your own due diligence checks, apply your own discretion and consult your competent advisors. The content of the website is not personally directed to you, and we does not take into account your financial situation or needs.The information contained in this website is not necessarily provided in real-time nor is it necessarily accurate. Prices provided herein may be provided by market makers and not by exchanges.Any trading or other financial decision you make shall be at your full responsibility, and you must not rely on any information provided through the website. FX Empire does not provide any warranty regarding any of the information contained in the website, and shall bear no responsibility for any trading losses you might incur as a result of using any information contained in the website.The website may include advertisements and other promotional contents, and FX Empire may receive compensation from third parties in connection with the content. FX Empire does not endorse any third party or recommends using any third party's services, and does not assume responsibility for your use of any such third party's website or services.FX Empire and its employees, officers, subsidiaries and associates, are not liable nor shall they be held liable for any loss or damage resulting from your use of the website or reliance on the information provided on this website.
RISK DISCLAIMER
This website includes information about cryptocurrencies, contracts for difference (CFDs) and other financial instruments, and about brokers, exchanges and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and come with a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money.FX Empire encourages you to perform your own research before making any investment decision, and to avoid investing in any financial instrument which you do not fully understand how it works and what are the risks involved.
FOLLOW US